Caplin Point Laboratories logo

Caplin Point Laboratories MD, chairman, board of directors and AGM

NSE: CAPLIPOINTBSE: 524742Pharmaceuticals & BiotechnologySmall Cap

Last close ₹2,222.00down ₹27.10 (1.20%)BSE ₹2,222.15

Share price at the NSE close on 23 Oct 2026. Previous close ₹2,249.10.

52-week range of traded prices to 23 Oct 2026
₹1,500.30Low, 30 Mar 2026₹2,990.00High, 24 Sep 2026
Market cap
₹16,890 Cr453rd largest listed
P/E
25.4
P/B
4.7
Dividend yield
0.36%
ROE
20.7%
ROCE
19.8%
Debt to equity
0.00
Volume, NSE
76,90447.0% delivered

Caplin Point Laboratories board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonC C Paarthipan
  • Managing directorSridhar Ganesan
  • Company Secretary and Compliance OfficerG Venkatram

9 directors5 independent1 executive3 non-executive

  • C C Paarthipan · ChairpersonNon-executive · joined Oct 1993 · reappointed Sep 2025 · 1 listed board
  • Sridhar Ganesan · Managing directorExecutive · joined Feb 2014 · reappointed Aug 2024 · 1 listed board · 2 committee seats
  • R NagendranIndependent · joined Sep 2022 · reappointed Sep 2022 · 45 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • S DeenadayalanIndependent · joined Sep 2022 · reappointed Sep 2022 · 45 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
  • Ranganathan VijayaraghavanIndependent · joined Sep 2024 · reappointed Sep 2024 · 21 months as independent · 3 listed boards · 3 as independent · 7 committee seats, 3 as chair
  • Ashok PartheebanNon-executive · joined Nov 2025 · 1 listed board
  • K C JohnIndependent · joined Nov 2025 · reappointed Nov 2025 · 7 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • Vivek PartheebanNon-executive · joined Nov 2025 · 1 listed board · 1 committee seat
  • Susan MathewIndependent · joined Jan 2026 · reappointed Jan 2026 · 5 months as independent · 1 listed board · 1 as independent · 1 committee seat

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

2 directors who left
  • C K Gariyali, left 3 Mar 2026: Tenure Completion
  • D Sathyanarayanan, left 8 Nov 2024: Tenure Completion

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 14 May 20268 of 9 present4 independent · 97 days in between
    • 5 Feb 20269 of 10 present5 independent

  • Audit Committee

    Chair Ranganathan Vijayaraghavan

    R Nagendran, Sridhar Ganesan, S Deenadayalan

    • 14 May 20263 of 4 present2 independent · 97 days in between
    • 5 Feb 20264 of 4 present3 independent

  • Nomination and remuneration committee

    Chair S Deenadayalan

    C C Paarthipan, K C John

    • 14 May 20263 of 3 present2 independent

  • Stakeholders Relationship Committee

    Chair S Deenadayalan

    Ranganathan Vijayaraghavan, Sridhar Ganesan

    • 5 Feb 20263 of 3 present2 independent

  • Risk Management Committee

    Chair S Deenadayalan

    Sridhar Ganesan, D Muralidharan, Vivek Partheeban, K C John

    • 5 Feb 20263 of 3 present1 independent

  • Corporate Social Responsibility Committee

    Chair C C Paarthipan

    S Deenadayalan, Sridhar Ganesan

    • 14 May 20263 of 3 present1 independent · 97 days in between
    • 5 Feb 20263 of 3 present1 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • Brahmayya & Co.Peer-review certificate valid to Apr 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Caplin Point Laboratories AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Caplin Point Laboratories dividend history

Annual general meeting, 25 Sep 2026

1,04,458 shareholders on the register on 18 Sep 2026; present: 6 promoters and 44 others; votes counted by M Alagar / Alagar & Associates LLP.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial year ended March 31, 2026, along with the Reports of the Board of Directors and the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 77.51% · promoters 100.00% · institutions 83.05% · other public 1.92%

  2. Declaration of Final Dividend and ratification of Interim Dividend
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 77.53% · promoters 100.00% · institutions 83.31% · other public 1.92%

  3. Retirement by rotation of Dr. Sridhar Ganesan (DIN: 06819026) and consideration of his re-appointment
    Ordinary
    99.00% for1.00% against

    Against: promoters 0.00% · institutions 11.86% · other public 0.07%

    Turnout: all 77.53% · promoters 100.00% · institutions 83.28% · other public 1.92%

  4. Re-appointment of Dr. Sridhar Ganesan (DIN: 06819026) as the Managing Director of the Company
    Special
    98.94% for1.06% against

    Against: promoters 0.00% · institutions 12.53% · other public 0.07%

    Turnout: all 77.53% · promoters 100.00% · institutions 83.28% · other public 1.92%

  5. Continuation of Mr. C. C. Paarthipan (DIN: 01218784) as the Chairman and Non-Executive, Non-Independent Director of the Company.
    SpecialPromoters have an interest in it
    98.72% for1.28% against

    Against: promoters 0.00% · institutions 15.19% · other public 0.38%

    Turnout: all 77.53% · promoters 100.00% · institutions 83.28% · other public 1.92%

  6. Appointment of Mr. D Muralidharan (DIN: 08301904) as a Whole Time Director of the Company
    Special
    96.78% for3.22% against

    Against: promoters 0.00% · institutions 38.13% · other public 0.50%

    Turnout: all 77.53% · promoters 100.00% · institutions 83.28% · other public 1.92%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 31 Jan 2026, 4 resolutions

94,896 shareholders on the register on 26 Dec 2025; votes counted by M Alagar / Alagar & Associates LLP.The company's voting result (opens in a new tab)

  1. Appointment of Mr. Ashok Partheeban (DIN: 02507261) as Director and Vice-Chairman of the Company
    OrdinaryPromoters have an interest in it
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 1.32% · other public 0.48%

    Turnout: all 78.35% · promoters 100.00% · institutions 87.35% · other public 0.48%

  2. Appointment of Mr. Vivek Partheeban (DIN: 02507289) as Director and Vice-Chairman of the Company
    OrdinaryPromoters have an interest in it
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 0.84% · other public 0.50%

    Turnout: all 78.35% · promoters 100.00% · institutions 87.35% · other public 0.48%

  3. Appointment of Dr. K C John (DIN: 01067374) as Non-Executive Independent Director of the Company for a term of five years
    Special
    96.71% for3.29% against

    Against: promoters 0.00% · institutions 33.55% · other public 0.37%

    Turnout: all 78.35% · promoters 100.00% · institutions 87.35% · other public 0.48%

  4. Appointment of Mrs. Susan Mathew (DIN: 00517738) as Non-Executive Independent Director of the Company for a term of five years
    Special
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 0.48% · other public 0.40%

    Turnout: all 78.35% · promoters 100.00% · institutions 87.35% · other public 0.48%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 22 Sep 2025, 4 resolutions

94,983 shareholders on the register on 15 Sep 2025; present: 2 promoters and 53 others; votes counted by M Alagar / Alagar & Associates LLP.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the year ended March 31, 2025, along with the Reports of the Board of Director’s and the Auditor’s thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 78.21% · promoters 100.00% · institutions 84.05% · other public 1.79%

  2. To declare final dividend and ratification of interim dividend
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 78.22% · promoters 100.00% · institutions 84.08% · other public 1.79%

  3. To re-appoint Mr. C.C Paarthipan (DIN: 01218784) who retires by rotation, and being eligible, offers himself for re-appointment
    OrdinaryPromoters have an interest in it
    99.85% for0.15% against

    Against: promoters 0.00% · institutions 1.63% · other public 0.18%

    Turnout: all 78.22% · promoters 100.00% · institutions 84.07% · other public 1.79%

  4. To appoint Secretarial Auditors of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.08%

    Turnout: all 78.21% · promoters 100.00% · institutions 84.06% · other public 1.79%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Sep 2024, 6 resolutions

Present: 7 promoters and 66 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the year ended March 31, 2024 along with the Reports of the Board of Director’s and the Auditor’s thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 76.54% · promoters 100.00% · institutions 82.01% · other public 6.14%

  2. To declare final dividend and ratification of interim dividend
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 76.54% · promoters 100.00% · institutions 82.05% · other public 6.14%

  3. To re-appoint Dr. Sridhar Ganesan (DIN: 06819026) who retires by rotation, and being eligible, offers himself for re-appointment
    Ordinary
    99.80% for0.20% against

    Against: promoters 0.00% · institutions 3.30% · other public 0.01%

    Turnout: all 76.41% · promoters 100.00% · institutions 82.05% · other public 5.60%

  4. To approve Fresh Material Related Party Transaction(s) / Contract(s) / Arrangement(s)
    OrdinaryPromoters have an interest in it
    99.39% for0.61% against

    Against: promoters 0.00% · institutions 0.78% · other public 0.01%

    Turnout: all 5.82% · promoters 0.00% · institutions 82.05% · other public 5.45%

  5. Re-appointment of Dr Sridhar Ganesan as the Managing Director of the Company.
    Special
    99.68% for0.32% against

    Against: promoters 0.00% · institutions 5.46% · other public 0.02%

    Turnout: all 76.41% · promoters 100.00% · institutions 82.05% · other public 5.60%

  6. To consider and approve the Appointment of Mr R Vijayaraghavan as an Independent Director of the Company.
    Special
    99.82% for0.18% against

    Against: promoters 0.00% · institutions 3.03% · other public 0.02%

    Turnout: all 76.54% · promoters 100.00% · institutions 82.05% · other public 6.14%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 21 Sep 2023, 6 resolutions

Present: 7 promoters and 54 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the year ended March 31, 2023 along with the Reports of the Board of Director’s and the Auditor’s thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 73.87% · promoters 100.00% · institutions 73.64% · other public 3.19%

  2. To declare a final dividend Rs. 2.5/- (125%) per equity share of Rs.2 as recommended by the Board of Directors of the company and to ratify the Interim Dividend of Rs.2 (100 %) per equity share of Rs. 2,aggregating to Rs.4.5(225%) for the year ended March 31,2023MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 73.88% · promoters 100.00% · institutions 74.00% · other public 3.19%

  3. To re-appoint Mr. C C Paarthipan (DIN: 01218784) who retires by rotation, and being eligible, offers himself for re-appointment
    OrdinaryPromoters have an interest in it
    99.69% for0.31% against

    Against: promoters 0.00% · institutions 9.34% · other public 0.07%

    Turnout: all 73.88% · promoters 100.00% · institutions 74.00% · other public 3.19%

  4. To appoint M/S Brahmayya and Co, Charted Accountants as the statutory auditors of the company
    Ordinary
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.36% · other public 0.58%

    Turnout: all 73.88% · promoters 100.00% · institutions 74.00% · other public 3.19%

  5. To approve material modifications to earlier approved Material Related Party Transaction(s)/Contract(s)/Arrangement(s).
    OrdinaryPromoters have an interest in it
    99.05% for0.95% against

    Against: promoters 0.00% · institutions 0.98% · other public 0.83%

    Turnout: all 3.08% · promoters 0.00% · institutions 74.00% · other public 2.55%

  6. To re-appoint Dr. Gariyali as an Independent Director
    Special
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 1.35% · other public 0.10%

    Turnout: all 73.88% · promoters 100.00% · institutions 74.00% · other public 3.19%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 29 Sep 2022, 10 resolutions

Present: 4 promoters and 66 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2022 along with the Reports of the Board of Directors and the Auditor's thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 76.27% · promoters 100.00% · institutions 73.90% · other public 17.90%

  2. To declare a final dividend of Rs. 2/- (100%) per equity share of Rs. 2/- as recommended by the Board of Directors of the Company and to ratify the Interim Dividend of Rs. 2/- (100 %) per equity share of Rs. 2/-, aggregating to Rs. 4 (200%) for the Financial Year ended March 31, 2022.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 76.27% · promoters 100.00% · institutions 73.90% · other public 17.90%

  3. To appoint a Director in place of Dr. Sridhar Ganesan (DIN: 06819026) who retires by rotation, and being eligible, offers himself for re-appointment.
    Ordinary
    99.36% for0.64% against

    Against: promoters 0.00% · institutions 20.21% · other public 0.00%

    Turnout: all 76.27% · promoters 100.00% · institutions 73.90% · other public 17.90%

  4. Re-appointment of M/s. CNGSN & Associates LLP as the Statutory Auditors of the Company
    Ordinary
    98.93% for1.07% against

    Against: promoters 0.00% · institutions 34.18% · other public 0.00%

    Turnout: all 76.27% · promoters 100.00% · institutions 73.90% · other public 17.90%

  5. Approval of Material Related Party Transaction(s) with NuevosEticos Neo Ethicals S.A - Guatemala
    OrdinaryPromoters have an interest in it
    84.96% for15.04% against

    Against: promoters 0.00% · institutions 33.36% · other public 0.02%

    Turnout: all 5.32% · promoters 0.00% · institutions 73.90% · other public 10.49%

  6. Approval of Material Related Party Transaction(s) with Caplin Steriles Limited
    OrdinaryPromoters have an interest in it
    84.96% for15.04% against

    Against: promoters 0.00% · institutions 33.36% · other public 0.01%

    Turnout: all 5.32% · promoters 0.00% · institutions 73.90% · other public 10.49%

  7. Approval for providing loans and guarantees under Section 185 of the Companies Act, 2013
    SpecialPromoters have an interest in it
    98.92% for1.08% against

    Against: promoters 0.00% · institutions 34.18% · other public 0.11%

    Turnout: all 76.21% · promoters 100.00% · institutions 73.90% · other public 17.67%

  8. To consider and approve the Re-appointment of Dr Sridhar Ganesan as the Managing Director of the Company
    Ordinary
    99.40% for0.60% against

    Against: promoters 0.00% · institutions 19.21% · other public 0.01%

    Turnout: all 76.27% · promoters 100.00% · institutions 73.90% · other public 17.90%

  9. To consider and approve the Appointment of Dr. R. Nagendran as an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 76.27% · promoters 100.00% · institutions 73.90% · other public 17.90%

  10. To consider and approve the Appointment of Mr. S. Deenadayalanas an Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 76.27% · promoters 100.00% · institutions 73.90% · other public 17.90%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 28 Sep 2021, 6 resolutions

Present: 5 promoters and 61 others.The company's voting result (opens in a new tab)

  1. Adoption of Financial Statements
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 73.77% · promoters 100.00% · institutions 52.89% · other public 11.34%

  2. Declaration of Final Dividend and Ratification of InterimnDividend
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 73.77% · promoters 100.00% · institutions 52.89% · other public 11.34%

  3. Appointment of Mr. C C Paarthipan as a Director liablento retire by rotation
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 73.77% · promoters 100.00% · institutions 52.89% · other public 11.34%

  4. Approval of Related Party Transactions
    OrdinaryPromoters have an interest in it
    99.53% for0.47% against

    Against: promoters 0.00% · institutions 1.27% · other public 0.02%

    Turnout: all 4.30% · promoters 0.00% · institutions 52.89% · other public 9.76%

  5. Caplin Point Laboratories Limited Employees Stock Option Plan, 2021 and Grant of Employee Stock Options to the Eligible Employees
    Special
    98.34% for1.66% against

    Against: promoters 0.00% · institutions 78.25% · other public 0.06%

    Turnout: all 73.77% · promoters 100.00% · institutions 52.89% · other public 11.34%

  6. Extension of Caplin Point Laboratories Limited Employees Stock Option Plan, 2021 to the Eligible Employees of the Group Company, Subsidiaries including Step-Down Subsidiaries and Associates of the CompanyMoreLess
    Special
    98.34% for1.66% against

    Against: promoters 0.00% · institutions 78.25% · other public 0.07%

    Turnout: all 73.77% · promoters 100.00% · institutions 52.89% · other public 11.34%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 25 Sep 2026, 9 fund houses so far (houses' deadline to file 15 Oct 2026)

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial year ended March 31, 2026, along with the Reports of the Board of Directors and the Auditors thereon.MoreLess
    9 for0 against
  • Declaration of Final Dividend and ratification of Interim Dividend
    9 for0 against
  • Retirement by rotation of Dr. Sridhar Ganesan (DIN: 06819026) and consideration of his re-appointment
    9 for0 against
  • Re-appointment of Dr. Sridhar Ganesan (DIN: 06819026) as the Managing Director of the Company
    Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundPrior approval of shareholders not obtained for the continuation of the Executive Director beyond the age of 70 years.
    • Edelweiss Mutual Fund, Navi Mutual FundNo governance concern identified w.r.t the profile, time commitments, past attendance and proposed remuneration of the proposed appointee. Non-Compliance with Section 196 of the Companies Act, 2013: Prior approval of shareholders not obtained for the continuation of the Executive Director beyond the age of 70 years.
    6 for3 against
  • Continuation of Mr. C. C. Paarthipan (DIN: 01218784) as the Chairman and Non-Executive, Non-Independent Director of the Company.
    9 for0 against
  • Appointment of Mr. D Muralidharan (DIN: 08301904) as a Whole Time Director of the Company
    Against Angel One Mutual Fund, Edelweiss Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundPrior approval of shareholders not obtained for the continuation of the Executive Director beyond the age of 70 years.
    • Edelweiss Mutual Fund, Navi Mutual FundNo governance concern identified w.r.t the profile, time commitments and proposed remuneration of the proposed appointee. Non-Compliance with Section 196 of the Companies Act, 2013: Prior approval of shareholders not obtained for the continuation of the Executive Director beyond the age of 70 years
    6 for3 against

Mutual fund votes, meeting of 31 Jan 2026, 17 fund houses

  • Appointment of Mr. Ashok Partheeban (DIN: 02507261) as Director and Vice-Chairman of the Company
    Against Angel One Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundTransparency concern: Lack of clarity regarding the basis for determining the remuneration received from the step-down subsidiary.
    • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundCompliant with law. No concern on the merits of director. Transparency concern: Lack of clarity regarding the basis for determining the remuneration received from the step-down subsidiary.
    • Kotak Mahindra Mutual FundAshok Partheeban, 43, is a part of the promoter family, with over 20 years of expertise in the pharmaceutical industry. He is Business Head - LATAM since 2002, where he heads the Group s strategic business and marketing operations across the Latin American region including Mexico, Colombia, Chile, and Central America. The company proposes to appoint him as Non-Executive Chairperson from 5 November 2025. He will not be entitled to any remuneration from the company but will continue to draw remuneration of USD 25,000 per month from Nuevos Eticos Neo Ethicals S.A., Guatemala, a step-down subsidiary, in his capacity as Business Head. The company has not disclosed the basis or methodology used to determine the remuneration. Hence, we do not support the resolution.
    10 for7 against
  • Appointment of Mr. Vivek Partheeban (DIN: 02507289) as Director and Vice-Chairman of the Company
    17 for0 against
  • Appointment of Dr. K C John (DIN: 01067374) as Non-Executive Independent Director of the Company for a term of five years
    Against Angel One Mutual Fund, Axis Mutual Fund, Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual Fund, Jio BlackRock Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund
    • Angel One Mutual FundGovernance Concern: Prolonged association at Group Level.
    • Axis Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual FundDr. K. C. John, 73, is Director, Faculty of Management, at Sri Ramchandra Institute of Higher Education & Research. He has over 35 years of experience in the fields of sustainable development, technology innovation, and entrepreneurship. He is former Managing Director of AGNITY Inc. and has served in several leadership positions such as Country General Manager & COO, GENBAND; and COO, BayPackets. Currently, he serves as an External Subject Matter Expert for the TIDCO Investment Committee. He served as an Independent Director on the board of the company from August 2014 till August 2022. He has also been serving as Independent Director on the board of Caplin Steriles Limited, a subsidiary of the company, from 8 August 2019. While computing the tenure of Independent Directors, we consider their overall association with the company/group. As his association with the group has already crossed ten years, we do not consider him as Independent and do not support his appointment as Independent Director. Amendments in SEBI’s LODR require directors having attained the age of 75 to be approved by shareholders through a special resolution. Since we do not support his appointment, we do not support his subsequent continuation on board.
    • Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundCompliant with law. No concern on the merits of director. Governance Concern: Prolonged association at Group Level.
    • Jio BlackRock Mutual FundDr. K. C. John, 73, is Director, Faculty of Management, at Sri Ramchandra Institute of Higher Education & Research. He has over 35 years of experience in the fields of sustainable development, technology innovation, and entrepreneurship. He is former Managing Director of AGNITY Inc. and has served in several leadership positions such as Country General Manager & COO, GENBAND; and COO, BayPackets. Currently, he serves as an External Subject Matter Expert for the TIDCO Investment Committee.He served as an Independent Director on the board of the company from August 2014 till August 2022. He has also been serving as Independent Director on the board of Caplin Steriles Limited, a subsidiary of the company, from 8 August 2019. While computing the tenure of Independent Directors, we consider their overall association with the company/group. As his association with the group has already crossed ten years, we do not consider him as Independent and do not support his appointment as Independent Director. Amendments in SEBI’s LODR require directors having attained the age of 75 to be approved by shareholders through a special resolution. Since we do not support his appointment, we do not support his subsequent continuation on board.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    • Nippon India Mutual FundGovernance Concern: Prolonged association with the Group.
    5 for12 against
  • Appointment of Mrs. Susan Mathew (DIN: 00517738) as Non-Executive Independent Director of the Company for a term of five years
    17 for0 against
6 earlier meetings

Mutual fund votes, meeting of 22 Sep 2025, 17 fund houses

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the year ended March 31, 2025, along with the Reports of the Board of Director’s and the Auditor’s thereonMoreLess
    17 for0 against
  • To declare final dividend and ratification of interim dividend
    17 for0 against
  • To re-appoint Mr. C.C Paarthipan (DIN: 01218784) who retires by rotation, and being eligible, offers himself for re-appointment
    17 for0 against
  • To appoint Secretarial Auditors of the Company
    17 for0 against

Mutual fund votes, meeting of 30 Sep 2024, 12 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the year ended March 31, 2024 along with the Reports of the Board of Director’s and the Auditor’s thereonMoreLess
    12 for0 against
  • To declare final dividend and ratification of interim dividend
    12 for0 against
  • To re-appoint Dr. Sridhar Ganesan (DIN: 06819026) who retires by rotation, and being eligible, offers himself for re-appointment
    12 for0 against
  • To approve Fresh Material Related Party Transaction(s) / Contract(s) / Arrangement(s)
    Against Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Nippon India Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual Fund, Nippon India Mutual FundNon-Compliant with SEBI LODR: Omnibus approval sought for more than 1 year. Governance & Transparency Concern: It is unclear how proposed transactions fall within the ordinary course of business.
    • Edelweiss Mutual FundIt is unclear how proposed transactions fall within the ordinary course of business.
    6 for4 against
  • Re-appointment of Dr Sridhar Ganesan as the Managing Director of the Company.
    Against Axis Mutual Fund, DSP Mutual Fund, Mirae Asset Mutual Fund
    • Axis Mutual Fund, DSP Mutual FundDr. Sridhar Ganesan, 69, is the Managing Director. He was last reappointed as MD for two years in the 2022 AGM. He was paid a remuneration of Rs. 5.6 mn in FY24 excluding ESOPs. While we support his reappointment as Managing Director, we do not support the resolution because of the open-ended remuneration structure. While his cash pay is not expected to exceed Rs. 6.1 mn in FY25, there is no clarity on the quantum of stock options he is expected to be granted. Details of past stock option grants are not available. As a result, we are unable to estimate his proposed remuneration. Since we do not have sufficient information to make an informed decision, we do not support the resolution.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    9 for3 against
  • To consider and approve the Appointment of Mr R Vijayaraghavan as an Independent Director of the Company.
    Against Axis Mutual Fund, DSP Mutual Fund, Mirae Asset Mutual Fund
    • Axis Mutual Fund, DSP Mutual FundR Vijayaraghavan, 75, is an Advocate in Chennai and has been practicing law for over thirty-five years. He has experience in the fields of corporate law, mergers and acquisitions, and tax laws. He holds a master’s degree in science from Madurai University and MBA from Syracuse University, USA and is a law graduate from Dr. Ambedkar Law College, Chennai. We note that with his directorship in Caplin Point Laboratories Limited, he will be an Independent Director on the board of four listed companies. Given their full-time responsibilities, regulations allow whole-time directors of listed companies to be independent directors in a maximum of three listed companies. We believe that as a practicing advocate, his responsibilities are equivalent to a whole-time directorship. His high number of directorships on listed companies is not in keeping with the spirit of the regulation. Therefore, we do not support his appointment. Regulations require companies to seek shareholder approval via a special majority for Independent Directors that have crossed the age threshold of 75 years – we do not consider age as a criterion for board membership.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    9 for3 against
2 proposals not matched to one resolution
  • 4) Approve material related party transactions of Caplin Point Laboratories and its subsidiaries with Caplin Steriles Limited (CSL), a 99.99% subsidiary, for five years from FY25.
    1 for0 against
  • Approve material related party transactions of Caplin Point Laboratories and its subsidiaries with Caplin Steriles Limited (CSL), a 99.99% subsidiary, for five years from FY25
    1 for0 against

Mutual fund votes, meeting of 21 Sep 2023, 4 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the year ended March 31, 2023 along with the Reports of the Board of Director’s and the Auditor’s thereon.MoreLess
    3 for0 against
  • To declare a final dividend Rs. 2.5/- (125%) per equity share of Rs.2 as recommended by the Board of Directors of the company and to ratify the Interim Dividend of Rs.2 (100 %) per equity share of Rs. 2,aggregating to Rs.4.5(225%) for the year ended March 31,2023MoreLess
    3 for0 against
  • To re-appoint Mr. C C Paarthipan (DIN: 01218784) who retires by rotation, and being eligible, offers himself for re-appointment
    3 for0 against
  • To appoint M/S Brahmayya and Co, Charted Accountants as the statutory auditors of the company
    3 for0 against
  • To approve material modifications to earlier approved Material Related Party Transaction(s)/Contract(s)/Arrangement(s).
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundNo concern on merit of proposed transactions. Technical Non-compliance with SEBI Circular: Omnibus approval of RPTs for a period of more than one year.
    2 for1 against
  • To re-appoint Dr. Gariyali as an Independent Director
    Against Motilal Oswal Mutual Fund
    • Motilal Oswal Mutual FundNo concern on the merit of proposed appointee. Non-Compliance: Proposed re-appointment is not in accordance with law. No prior shareholders’ approval obtained for re-appointment as ID and continuation of directorship beyond 75 years of age.
    3 for1 against
5 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 3, as a fund house numbered it
    1 for0 against
  • Item 4, as a fund house numbered it
    1 for0 against
  • Item 5, as a fund house numbered it
    1 for0 against

Mutual fund votes, meeting of 29 Sep 2022, 4 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2022 along with the Reports of the Board of Directors and the Auditor's thereon.MoreLess
    3 for0 against
  • To declare a final dividend of Rs. 2/- (100%) per equity share of Rs. 2/- as recommended by the Board of Directors of the Company and to ratify the Interim Dividend of Rs. 2/- (100 %) per equity share of Rs. 2/-, aggregating to Rs. 4 (200%) for the Financial Year ended March 31, 2022.MoreLess
    3 for0 against
  • To appoint a Director in place of Dr. Sridhar Ganesan (DIN: 06819026) who retires by rotation, and being eligible, offers himself for re-appointment.
    3 for0 against
  • Re-appointment of M/s. CNGSN & Associates LLP as the Statutory Auditors of the Company
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundProposed appointment of auditor is for 1 year instead of 5 years
    2 for1 against
  • Approval of Material Related Party Transaction(s) with NuevosEticos Neo Ethicals S.A - Guatemala
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundOmnibus approval for more than one year
    3 for1 against
  • Approval of Material Related Party Transaction(s) with Caplin Steriles Limited
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundOmnibus approval for more than one year
    3 for1 against
  • Approval for providing loans and guarantees under Section 185 of the Companies Act, 2013
    Against Nippon India Mutual Fund
    • Nippon India Mutual FundInadequate disclosure
    2 for1 against
  • To consider and approve the Re-appointment of Dr Sridhar Ganesan as the Managing Director of the Company
    3 for0 against
  • To consider and approve the Appointment of Dr. R. Nagendran as an Independent Director of the Company
    3 for0 against
10 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 3, as a fund house numbered it
    1 for0 against
  • Item 4, as a fund house numbered it
    1 for0 against
  • Item 7, as a fund house numbered it
    1 for0 against
  • Item 8, as a fund house numbered it
    1 for0 against
  • Item 9, as a fund house numbered it
    1 for0 against
  • Item 10, as a fund house numbered it
    1 for0 against
  • To appoint Mr. S. Deenadayalan (DIN: 01951620) as an Independent Director of the Company for a term of five years i.e., from the conclusion of the 31st Annual General Meeting and whose term is not liable to retire by rotationMoreLess
    1 for0 against
  • To consider and approve the Appointment of Mr. S. Deenadayalan (DIN: 01951620), as an Independent Director of the Company for a term of five years i.e., from the conclusion of the 31st Annual General Meeting and whose term is not liable to retire by rotation.MoreLess
    2 for0 against

Mutual fund votes, meeting of 28 Sep 2021, 5 fund houses

  • Adoption of Financial Statements
    5 for0 against
  • Declaration of Final Dividend and Ratification of InterimnDividend
    4 for0 against
  • Appointment of Mr. C C Paarthipan as a Director liablento retire by rotation
    4 for0 against
  • Approval of Related Party Transactions
    4 for0 against
  • Caplin Point Laboratories Limited Employees Stock Option Plan, 2021 and Grant of Employee Stock Options to the Eligible Employees
    Against Franklin Templeton Mutual Fund, Nippon India Mutual Fund
    • Franklin Templeton Mutual FundA vote AGAINST this resolution is warranted because: • The Scheme permits stock options to be issued with an exercise price at a discount to the market price as on date of grant.
    • Nippon India Mutual FundInsufficient Information
    2 for2 against
  • Extension of Caplin Point Laboratories Limited Employees Stock Option Plan, 2021 to the Eligible Employees of the Group Company, Subsidiaries including Step-Down Subsidiaries and Associates of the CompanyMoreLess
    Against Franklin Templeton Mutual Fund, Nippon India Mutual Fund
    • Franklin Templeton Mutual FundA vote AGAINST this resolution is warranted because: • The Scheme permits stock options to be issued with an exercise price at a discount to the market price as on date of grant.
    • Nippon India Mutual FundInsufficient Information
    2 for2 against

Mutual fund votes, meeting of 28 Sep 2020, 3 fund houses

  • Accept Financial Statements and Statutory Reports
    1 for0 against
  • Adoption Of Financial Statements
    0 for0 against

    1 abstained

  • Appointment Of Dr C K Gariyali As A Non-Executive Independent Director
    0 for0 against

    1 abstained

  • Appointment Of Mr D P Mishra As A Director Liable To Retire By Rotation
    0 for0 against

    1 abstained

  • Approval For Related Party Transactions
    0 for0 against

    1 abstained

  • Approve Reappointment and Remuneration of Sridhar Ganesan as Managing Director
    1 for0 against
  • Approve Related Party Transactions
    1 for0 against
  • Declaration Of Final Dividend And Ratification Of Interim Dividend
    0 for0 against

    1 abstained

  • Declare Final Dividend and Confirm Interim Dividend
    1 for0 against
  • Elect C K Gariyali as Director
    1 for0 against
  • Re-Appointment Of Dr Sridhar Ganesan As A Managing Director
    0 for0 against

    1 abstained

  • Reelect D P Mishra as Director
    Against Franklin Templeton Mutual Fund
    • Franklin Templeton Mutual FundA vote AGAINST Durga Prasanna Mishra (Item 3) is warranted because he has failed to attend at least 75 percent of board and committee meetings in the most recent fiscal year, without a satisfactory explanation.
    0 for1 against
  • To appoint a Director in place of Mr D P Mishra (DIN: 02032818), who retires by rotation and being eligible, offers himself for reappointment.
    0 for0 against

    1 abstained

  • To appoint Dr C K Gariyali (DIN :08711546), as a Non-Executive Independent Director of the Company for a term of three consecutive years i.e. from March 04,2020 to March 03,2023 and she shall not be liable to retire by rotationMoreLess
    0 for0 against

    1 abstained

  • To authorise the Board of Directors of the Company to enter into contracts/ arrangements/ transactions with related parties within the meaning of Section2(76) of the Companies Act,2013 and 2(1)(zb) of SEBI (Listing Obligations and Disclosure Requirements)Regulations,2015 on such terms and conditions as the Board may deem fit, for the Financial year 2020- 21, provided that the said contract/ arrangements/ transactions shall be so carried out on Arm’s length basis and in normal course of business.MoreLess
    0 for0 against

    1 abstained

  • To declare a final dividend of Rs. 0.40 paise (20%) per equity share of Rs. 2/- each and to confirm and ratify interim dividend of Rs. 2.10 paise (105%) per equity share of Rs. 2/- each, already paid during the year, (aggregating to Rs. 2.50 paise (125%) for the financial year ended March 31,2020MoreLess
    0 for0 against

    1 abstained

  • To re-appoint Dr. Sridhar Ganesan (DIN: 06819026), as a Managing Director of the Company for the period of two years with effect from August 25,2020 and to fix remuneration
    0 for0 against

    1 abstained

  • To receive, consider and adopt audited Standalone and Consolidated financial statements of the Company for the financial year ended March 31, 2020, including audited Balance Sheet as at March 31, 2020 and Statement of Profit and Loss of the Company for the year ended as on that date along with the reports of the Board of Directors and Auditors thereonMoreLess
    0 for0 against

    1 abstained

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 9 complaints open, quarter to Mar 2026.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.